Vizgen

About

Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.

Cambridge,Massachusetts,United States
51 - 100
https://www.vizgen.com

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $85.20M
Industries: Biotechnology,Health Care,Life Science,Medical
Founded date: Mar 7, 2019
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Vizgen, Inc.

Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution. The high throughput and resolution and the low cost per cell achieved by the technology will enable a wide range of tissue-scale basic research and development and will be instrumental to efforts to discover and map cell types and states in a range of tissues and organisms.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$136.20M

Vizgen has raised a total of $136.20M in funding over 2 rounds. Their latest funding was raised on Jun 3, 2022 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 3, 2022	Series C	$85.20M	7	ARCH Venture Partners Blue Water Life Science Advisors	—	Detail
Apr 7, 2021	Series B	$37M	6	Northpond Ventures Novalis LifeSciences	—	Detail
Jan 30, 2020	Series A	$14M	2	ARCH Venture Partners Northpond Ventures	—	Detail

Investments

Number of Investments

Number of Lead Investments

8

0

Vizgen has made 8 investments. Their most recent investment was on Dec 8, 2022, when Metagood raised $5M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 8, 2022 Metagood	Pre-seed	$5M	Cryptocurrency	—
Jul 14, 2022 Trend	Pre-seed	$3M	Advertising Platforms	—
Mar 4, 2022 Block Tackle	Seed	$5M	Blockchain	—
Jan 11, 2022 Lootex	Seed	$9M	Blockchain	—
Jan 5, 2022 CryptoSlam	Seed	$9M	Blockchain	—

Investors

Number of Lead Investors

Number of Investors

6

9

Vizgen is funded by 9 investors. ARCH Venture Partners and Blue Water Life Science Advisors are the most recent investors.

Investor Name	Lead Investor	Funding Round
ARCH Venture Partners	Yes	Series C
Blue Water Life Science Advisors	Yes	Series C
David Walt	—	Series C
Northpond Ventures	—	Series C
Novalis LifeSciences	—	Series C
Sofina	—	Series C
Tao Capital Partners	—	Series C
David R. Walt	—	Series B
Pura Vida Investments	—	Series B